| Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review BM Mathers, L Degenhardt, B Phillips, L Wiessing, M Hickman, ... The Lancet 372 (9651), 1733-1745, 2008 | 1723 | 2008 |
| SARS-CoV-2 spike mutations, L452R, T478K, E484Q and P681R, in the second wave of COVID-19 in Maharashtra, India S Cherian, V Potdar, S Jadhav, P Yadav, N Gupta, M Das, P Rakshit, ... Microorganisms 9 (7), 1542, 2021 | 831* | 2021 |
| Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial R Ella, KM Vadrevu, H Jogdand, S Prasad, S Reddy, V Sarangi, ... The Lancet Infectious Diseases 21 (5), 637-646, 2021 | 475 | 2021 |
| Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial R Ella, S Reddy, W Blackwelder, V Potdar, P Yadav, V Sarangi, VK Aileni, ... The Lancet 398 (10317), 2173-2184, 2021 | 386 | 2021 |
| Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a … R Ella, S Reddy, H Jogdand, V Sarangi, B Ganneru, S Prasad, D Das, ... The Lancet Infectious Diseases 21 (7), 950-961, 2021 | 382 | 2021 |
| Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses H Pan, R Peto, AMH Restrepo, MP Preziosi, V Sathiyamoorthy, QA Karim, ... The Lancet 399 (10339), 1941-1953, 2022 | 290 | 2022 |
| Neutralization of variant under investigation B. 1.617. 1 with sera of BBV152 vaccinees PD Yadav, GN Sapkal, P Abraham, R Ella, G Deshpande, DY Patil, ... Clinical Infectious Diseases 74 (2), 366-368, 2022 | 280 | 2022 |
| Healthcare workers & SARS-CoV-2 infection in India: A case-control investigation in the time of COVID-19 P Chatterjee, T Anand, KJ Singh, R Rasaily, R Singh, S Das, H Singh, ... Indian Journal of Medical Research 151 (5), 459-467, 2020 | 273 | 2020 |
| Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020 MV Murhekar, T Bhatnagar, S Selvaraju, K Rade, V Saravanakumar, ... Indian Journal of Medical Research 152 (1-2), 48-60, 2020 | 217 | 2020 |
| Meth/amphetamine use and associated HIV: Implications for global policy and public health L Degenhardt, B Mathers, M Guarinieri, S Panda, B Phillips, SA Strathdee, ... International Journal of Drug Policy 21 (5), 347-358, 2010 | 204 | 2010 |
| SARS-CoV-2 antibody seroprevalence in India, August–September, 2020: findings from the second nationwide household serosurvey MV Murhekar, T Bhatnagar, S Selvaraju, V Saravanakumar, ... The Lancet Global Health 9 (3), e257-e266, 2021 | 198 | 2021 |
| Rapid spread of HIV among injecting drug users in north-eastern states of India S Sarkar, N Das, S Panda, TN Naik, K Sarkar, BC Singh, JM Ralte, ... Bull Narc 45 (1), 91-105, 1993 | 178 | 1993 |
| Secondary infections in hospitalized COVID-19 patients: Indian experience S Vijay, N Bansal, BK Rao, B Veeraraghavan, C Rodrigues, C Wattal, ... Infection and drug resistance, 1893-1903, 2021 | 162 | 2021 |
| Transmission of HIV from injecting drug users to their wives in India S Panda, A Chatterjee, SK Bhattacharya, B Manna, PN Singh, S Sarkar, ... International journal of STD & AIDS 11 (7), 468-473, 2000 | 160 | 2000 |
| Inactivated COVID-19 vaccine BBV152/COVAXIN effectively neutralizes recently emerged B. 1.1. 7 variant of SARS-CoV-2 GN Sapkal, PD Yadav, R Ella, GR Deshpande, RR Sahay, N Gupta, ... Journal of Travel Medicine 28 (4), taab051, 2021 | 151 | 2021 |
| SARS-CoV-2 seroprevalence among the general population and healthcare workers in India, December 2020–January 2021 MV Murhekar, T Bhatnagar, JWV Thangaraj, V Saravanakumar, ... International Journal of Infectious Diseases 108, 145-155, 2021 | 142 | 2021 |
| Prevalence of HCV & HBV infection amongst HIV seropositive MK Saha, S Chakrabarti, S Panda, TN Naik, B Manna, A Chatterjee, ... Indian journal of medical research 111, 37-9, 2000 | 111 | 2000 |
| Neutralization of Beta and Delta variant with sera of COVID-19 recovered cases and vaccinees of inactivated COVID-19 vaccine BBV152/Covaxin PD Yadav, GN Sapkal, R Ella, RR Sahay, DA Nyayanit, DY Patil, ... Journal of Travel Medicine 28 (7), taab104, 2021 | 110 | 2021 |
| Risk factors for HIV infection in injection drug users and evidence for onward transmission of HIV to their sexual partners in Chennai, India S Panda, MS Kumar, S Lokabiraman, K Jayashree, MC Satagopan, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 39 (1), 9-15, 2005 | 109 | 2005 |
| Immunogenicity and protective efficacy of inactivated SARS-CoV-2 vaccine candidate, BBV152 in rhesus macaques PD Yadav, R Ella, S Kumar, DR Patil, S Mohandas, AM Shete, ... Nature communications 12 (1), 1386, 2021 | 102 | 2021 |
Pragya D YadavScientistVerified email at gov.in
